Literature DB >> 21825961

Clinical spectrum and outcome of Nocardia infection: experience of 15-year period from a single tertiary medical center.

Emilia Hardak1, Mordechai Yigla, Gidon Berger, Hannah Sprecher, Ilana Oren.   

Abstract

INTRODUCTION: Nocardiosis, although very rare, is considered as an important opportunistic infection; however, recent literature is limited. This study describes all cases of nocardial infection treated in the authors' hospital to provide more information about clinical manifestations, species isolated, treatment and outcome of patients with nocardiosis.
METHODS: A retrospective review of the clinical features and outcome of nocardial infections was conducted during a 15-year period (1996-2010) at Rambam Health Care Campus.
RESULTS: The study included 53 patients with nocardial infection, 43 of them had underlying immunodeficiency. The most common clinical form was pulmonary nocardiosis with and without dissemination (60%), followed by skin and soft tissue infection (21%), bacteremia (11%) and pertonitis (5%). Resistance to trimethoprim/sulfamethoxazile was detected in 15% of isolates; to imipenem in 5% and to ciprofloxacin in 65%. Overall mortality was 25% (13/53), mainly observed in patients with pulmonary involvement (37.5%).
CONCLUSIONS: Nocardiosis is a rare infection and mainly affects immunocompromised patients. Higher index of suspicion is needed for earlier diagnosis and treatment to improve prognosis.

Entities:  

Mesh:

Year:  2012        PMID: 21825961     DOI: 10.1097/MAJ.0b013e31822cb5dc

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  16 in total

1.  Necrotizing Cutaneous Nocardiosis of the Hand: A Case Report and Review of the Literature.

Authors:  Joseph A Ricci; Ana A Weil; Kyle R Eberlin
Journal:  J Hand Microsurg       Date:  2015-01-10

Review 2.  Nocardiosis: A Neglected Disease.

Authors:  Shalini Dewan Duggal; Tulsi Das Chugh
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

3.  Nocardia pneumonia in an HIV-infected neonate presenting as acute necrotising pneumonia.

Authors:  Pierre Goussard; Robert Gie; Helena Rabie; Savvas Andronikou
Journal:  BMJ Case Rep       Date:  2013-07-31

Review 4.  Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Authors:  Cândida Abreu; Nuno Rocha-Pereira; António Sarmento; Fernando Magro
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  A ten-year retrospective analysis of nocardiosis in a tertiary care center of South-coastal India.

Authors:  Chandrashekar Udyavara Kudru; Abishek Kumar; Kiran Chawla; Cheshmitha Minnamreddigari; Nayana Siddalingaiah; Vasudeva Guddattu
Journal:  Infez Med       Date:  2021-12-10

6.  Diversity and frequency of Nocardia spp. in the soil of Isfahan province, Iran.

Authors:  R Kachuei; M Emami; R Mirnejad; M Khoobdel
Journal:  Asian Pac J Trop Biomed       Date:  2012-06

7.  Nocardia colonization in contrast to nocardiosis: a comparison of patients' clinical characteristics.

Authors:  Ili Margalit; Khitam Muhsen; Yaara Ben Ari; Haim Ben-Zvi; Yael Shostak; Ilan Krause; Elad Goldberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-20       Impact factor: 3.267

8.  Blood culture positive Nocardia asteroides infection: a case report.

Authors:  Wolfgang Höpler; Hermann Laferl; Marton Szell; Peter Pongratz; Irmgard Brandl; Gerhard Tucek; Christoph Wenisch
Journal:  Wien Med Wochenschr       Date:  2012-11-28

9.  Nocardia Colonization: A Risk Factor for Lung Deterioration in Cystic Fibrosis Patients?

Authors:  Adi Dagan; Nathan Keller; Daphna Vilozni; Reut Ramon-Saraf; Bat-El Bar; Ifat Sarouk; Moshe Ashkenazi; Moran Lavie; Ori Efrati
Journal:  Med Sci Monit       Date:  2015-06-30

Review 10.  Nocardiosis in transplant recipients.

Authors:  D Lebeaux; E Morelon; F Suarez; F Lanternier; A Scemla; P Frange; J-L Mainardi; M Lecuit; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.